Receptos Pharmaceuticals Inc Acquires Apoptos Inc for Undisclosed Sum

  • Feed Type
  • Date
    6/26/2009
  • Company Name
    Apoptos Inc
  • Mailing Address
    10835 Road to the Cure San Diego, CA 92121
  • Company Description
    Apoptos Inc. is focused on developing novel small molecule drug therapies that directly induce tumor cell apoptosis. Using founding technology licensed from Burnham Institute for Medical Research, Fred Hutchinson Cancer Research Center, and Torrey Pines Institute for Molecular Studies, Apoptos is pioneering its anticancer platforms in close collaborations with preeminent scientists in the fields of apoptosis and experimental cancer therapy. Evasion of apoptosis pathways is central to cancer cell survival and reactivation of these cell-death pathways offers attractive anticancer drug development opportunities.
  • Website
    http://www.apoptos.com
  • Transaction Type
    M&A
  • Transaction Amount
    Undisclosed
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Financial terms of the transaction were not disclosed.

By posting a comment, you agree to our terms and conditions.